Has Sabine Saint Vil received payments from drug or device companies?

Yes. Drug and device makers reported $7,816 in general payments to Sabine Saint Vil across 306 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sabine Saint Vil did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sabine Saint Vil come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sabine Saint Vil

Physician Assistant · New Hyde Park, NYNPI 1376872283

Payments from drug & device makers

$7,816in general payments, 2019–2025

Across 306 payments — averaging $25.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$2K
Merck$840
E.r. Squibb & Sons, L.L.C.$776
Abbott$667
Amgen$571
AstraZeneca$546
plus $3K from 21 others

What the payments were for

Food & beverage$7,816100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	43	$1,559
Merck	36	$840
E.r. Squibb & Sons, L.L.C.	35	$776
Abbott	10	$667
Amgen	26	$571
AstraZeneca	21	$546
Pfizer	36	$503
Novo Nordisk	26	$454
Novartis	23	$392
Boston Scientific	6	$336
Lilly USA, LLC	6	$200
Boehringer Ingelheim	6	$147
Lexicon Pharmaceuticals, Inc.	6	$135
Bayer	1	$122
Edwards Lifesciences	4	$113
Esperion Therapeutics, Inc.	4	$90
Kiniksa Pharmaceuticals International, PLC	3	$62
Bridgebio Pharma, Inc.	3	$58
Dexcom, Inc.	2	$43
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$40
Atricure, Inc.	1	$32
Alnylam Pharmaceuticals Inc.	1	$29
Althera Pharmaceuticals LLC	1	$26
Tactile Systems Technology Inc	1	$25
GSK	1	$21
Altathera Pharmaceuticals LLC	1	$17
Heartflow, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,816 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	178	$218,561
EntrestoSacubitril/Valsartan	44	$65,206
XareltoRivaroxaban	48	$58,941
FarxigaDapagliflozin Propanediol	15	$16,090
Repatha SureclickEvolocumab	20	$12,782
Metoprolol Succinate	209	$3,514
Rosuvastatin Calcium	81	$1,755
Amlodipine Besylate	203	$1,396
Losartan Potassium	114	$1,282
Atorvastatin Calcium	106	$1,005
Nebivolol Hcl	14	$918
Diltiazem 24hr Er (Cd)Diltiazem Hcl	19	$912
Hydralazine Hcl	63	$873
Valsartan	14	$680
Metoprolol Tartrate	62	$482

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$503	$218,561178 claims
NovartisEntresto	$392	$65,20644 claims
Johnson & JohnsonXarelto	$1,559	$58,94148 claims
AstraZenecaFarxiga	$546	$16,09015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in New Hyde Park

Henry YuBronx$1M
Michael AsbachAmherst$962K
Janelle BunceJamestown$565K
Kristyl Cuenca-SiskoNew York$478K
Melissa WhiteGarden City$320K
Lawrence HermanHolbrook$315K
Kaitlyn NelsonBrooklyn$289K
Sari KatzGarden City$271K
Julius NwosuBronx$256K
Cameron KiserNew York$225K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →